Span Diagnostics has disinvested its entire 45% stake held in Joint Venture Company (JVC) namely Span Nihon Kohden Diagnostics. The company has disinvested the same to Nihon Khoden Corporation, Japan for consideration of Rs 8.02 crore.
Span Diagnostics caters to several different sections of diagnostics like Immunology, Biochemistry, Microbiology, Serology, Histopathology and instrumentation. The company’s manufacturing capabilities comprise of advanced infrastructure, highly trained and motivated pool of scientific and technical personnel and years of experience.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: